MC2151A1 - Derives d'acides amines - Google Patents

Derives d'acides amines

Info

Publication number
MC2151A1
MC2151A1 MC902146A MC2146A MC2151A1 MC 2151 A1 MC2151 A1 MC 2151A1 MC 902146 A MC902146 A MC 902146A MC 2146 A MC2146 A MC 2146A MC 2151 A1 MC2151 A1 MC 2151A1
Authority
MC
Monaco
Prior art keywords
amino acid
acid derivatives
derivatives
amino
acid
Prior art date
Application number
MC902146A
Other languages
English (en)
Inventor
Branca Quirico
Neidhart Werner
Ramuz Henri
Stadler Heinz
Wostl Wolfgang
Original Assignee
Hoffmann La Roche
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoffmann La Roche filed Critical Hoffmann La Roche
Publication of MC2151A1 publication Critical patent/MC2151A1/fr

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C311/00—Amides of sulfonic acids, i.e. compounds having singly-bound oxygen atoms of sulfo groups replaced by nitrogen atoms, not being part of nitro or nitroso groups
    • C07C311/22—Sulfonamides, the carbon skeleton of the acid part being further substituted by singly-bound oxygen atoms
    • C07C311/23—Sulfonamides, the carbon skeleton of the acid part being further substituted by singly-bound oxygen atoms having the sulfur atoms of the sulfonamide groups bound to acyclic carbon atoms
    • C07C311/25—Sulfonamides, the carbon skeleton of the acid part being further substituted by singly-bound oxygen atoms having the sulfur atoms of the sulfonamide groups bound to acyclic carbon atoms of a saturated carbon skeleton containing rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/06—Dipeptides
    • C07K5/06008—Dipeptides with the first amino acid being neutral
    • C07K5/06078—Dipeptides with the first amino acid being neutral and aromatic or cycloaliphatic
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Molecular Biology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Peptides Or Proteins (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Thiazole And Isothizaole Compounds (AREA)
  • Pyrrole Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Heterocyclic Compounds Containing Sulfur Atoms (AREA)
MC902146A 1989-09-04 1990-08-30 Derives d'acides amines MC2151A1 (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
CH319289 1989-09-04
CH233690 1990-07-12

Publications (1)

Publication Number Publication Date
MC2151A1 true MC2151A1 (fr) 1992-03-10

Family

ID=25690187

Family Applications (1)

Application Number Title Priority Date Filing Date
MC902146A MC2151A1 (fr) 1989-09-04 1990-08-30 Derives d'acides amines

Country Status (14)

Country Link
US (1) US5688946A (fr)
EP (1) EP0416373A3 (fr)
JP (1) JPH0399047A (fr)
KR (1) KR910006224A (fr)
AU (1) AU646640B2 (fr)
CA (1) CA2023099A1 (fr)
FI (1) FI904360A0 (fr)
HU (1) HUT58060A (fr)
IE (1) IE903197A1 (fr)
IL (1) IL95503A0 (fr)
MC (1) MC2151A1 (fr)
NO (1) NO903832L (fr)
NZ (1) NZ235057A (fr)
PT (1) PT95192A (fr)

Families Citing this family (29)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IE68045B1 (en) * 1990-05-11 1996-05-15 Abbott Lab Renin inhibitors
US5275950A (en) * 1990-05-11 1994-01-04 Abbott Laboratories Process for the preparation of a renin inhibiting compound
US5278161A (en) * 1990-06-28 1994-01-11 Hoffmann-La Roche Inc. Amino acid derivatives useful as renin inhibitors
DE4040056A1 (de) * 1990-12-14 1992-06-17 Merck Patent Gmbh Saeureamide
TW198712B (fr) * 1991-04-17 1993-01-21 Hoffmann La Roche
US5268361A (en) * 1991-06-07 1993-12-07 Sri International Hydroxyazido derivatives and related compounds as renin inhibitors
CA2095671A1 (fr) * 1992-06-04 1993-12-05 Quirico Branca Derives d'acide amine
US5317039A (en) * 1992-07-20 1994-05-31 G. D. Searle & Co. Cyclopropyl-alanine aryl/alkylsulfide/sulfonyl-terminated amino-diol compounds for treatment of hypertension
US5559256A (en) * 1992-07-20 1996-09-24 E. R. Squibb & Sons, Inc. Aminediol protease inhibitors
US5246969A (en) * 1992-07-20 1993-09-21 G. D. Searle & Co. Di-propargyl-containing aryl/alkylsulfonyl-terminated alanine amino-diol compounds for treatment of hypertension
US5314920A (en) * 1992-07-20 1994-05-24 G. D. Searle & Co. Ethynyl-alanine aryl/alkylsulfonyl-terminated amino-diol compounds for treatment of hypertension
US5268391A (en) * 1992-07-20 1993-12-07 C. D. Searle & Co. Propargyl-terminated cycloalkylalkyl-P2-site substituted aryl/alkylsulfonyl-terminated alanine amino-diol compounds for treatment of hypertension
US5212185A (en) * 1992-08-14 1993-05-18 G. D. Searle & Co. Piperidinyl-terminated alkylamino ethynyl alanine amino diol compounds for treatment of hypertension
US5312838A (en) * 1992-09-21 1994-05-17 G. D. Searle & Co. β-alanineamide aryl/alkylsulfide/sulfonyl-terminated amino-diol compounds for treatment of hypertension
ES2100109B1 (es) * 1993-07-14 1998-02-16 Squibb & Sons Inc Inhibidores de proteasas de aminodiol.
US5414018A (en) * 1993-09-24 1995-05-09 G. D. Searle & Co. Alkylaminoalkyl-terminated sulfide/sulfonyl-containing propargyl amino-diol compounds for treatment of hypertension
US5416119A (en) * 1993-10-25 1995-05-16 G. D. Searle & Co. Alkylaminoalkyl-terminated sulfide/sulfonyl-containing cycloalkyl-alanine amino-diol compounds for treatment of hypertension
US5432201A (en) * 1993-11-22 1995-07-11 G. D. Searle & Co. Alkylaminoalkyl-sulfonyl-terminated β-alanineamide amino-diol compounds for treatment of hypertension
BR9912516A (pt) * 1998-07-06 2001-09-18 Guilford Pharm Inc Inibidores de naaladase úteis como compostos e composições farmacêuticas
CA2360740A1 (fr) * 1999-03-02 2000-09-08 Boehringer Ingelheim Pharmaceuticals, Inc. Composes utiles en tant qu'inhibiteurs reversibles de la cathepsine s
JP2002201168A (ja) * 2000-12-28 2002-07-16 Kaken Pharmaceut Co Ltd シクロヘキサン誘導体
US20020147312A1 (en) * 2001-02-02 2002-10-10 O'keefe Theresa Hybrid antibodies and uses thereof
US6818787B2 (en) 2001-06-11 2004-11-16 Xenoport, Inc. Prodrugs of GABA analogs, compositions and uses thereof
US8048917B2 (en) 2005-04-06 2011-11-01 Xenoport, Inc. Prodrugs of GABA analogs, compositions and uses thereof
US7186855B2 (en) 2001-06-11 2007-03-06 Xenoport, Inc. Prodrugs of GABA analogs, compositions and uses thereof
US7232924B2 (en) 2001-06-11 2007-06-19 Xenoport, Inc. Methods for synthesis of acyloxyalkyl derivatives of GABA analogs
UA108742C2 (uk) 2009-09-23 2015-06-10 Фармацевтична композиція для лікування запальних захворювань, опосередкованих mcp-1
WO2015049239A1 (fr) * 2013-10-04 2015-04-09 Solvay Specialty Polymers Italy S.P.A. Procédé de synthèse de sels de sulfonate de fluoralkyle
AU2017326611A1 (en) * 2016-09-18 2019-05-02 H. Lee Moffitt Cancer Center And Research Institute, Inc. YAP1 inhibitors that target the interaction of YAP1 with Oct4

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4652551A (en) * 1984-06-22 1987-03-24 Abbott Laboratories Renin inhibiting compounds
US4845079A (en) * 1985-01-23 1989-07-04 Luly Jay R Peptidylaminodiols
WO1987004349A1 (fr) * 1986-01-16 1987-07-30 Joseph Dellaria Analogues de peptides
NZ218937A (en) * 1986-01-16 1990-03-27 Abbott Lab Functionalised peptidyl aminodiols and -triols as renin inhibitors and pharmaceutical compositions
US4726941A (en) * 1986-01-23 1988-02-23 Regents Of The University Of Minnesota Acylated cyanamide composition for treating ethanol ingestion
US5032577A (en) * 1986-12-31 1991-07-16 Abbott Laboratories Peptidylaminodiols
EP0309766B1 (fr) * 1987-09-29 1998-04-15 Banyu Pharmaceutical Co., Ltd. Dérivés N-acylés d'aminoacides et leur utilisation
EP0313847A3 (fr) * 1987-10-01 1989-11-29 G.D. Searle & Co. Alpha-succinamidoacyl aminodiols non peptidiques comme agents anti-hypertensifs
CA1328333C (fr) * 1988-03-04 1994-04-05 Quirico Branca Derives d'acide amine
TW225540B (fr) * 1990-06-28 1994-06-21 Shionogi & Co
AU8478191A (en) * 1990-09-27 1992-04-02 Merk & Co., Inc. Fibrinogen receptor antagonists

Also Published As

Publication number Publication date
EP0416373A2 (fr) 1991-03-13
NO903832D0 (no) 1990-09-03
IL95503A0 (en) 1991-06-30
CA2023099A1 (fr) 1991-03-05
US5688946A (en) 1997-11-18
PT95192A (pt) 1991-05-22
FI904360A0 (fi) 1990-09-04
HUT58060A (en) 1992-01-28
IE903197A1 (en) 1991-03-13
JPH0399047A (ja) 1991-04-24
NZ235057A (en) 1994-12-22
AU646640B2 (en) 1994-03-03
HU905676D0 (en) 1991-03-28
KR910006224A (ko) 1991-04-27
NO903832L (no) 1991-03-05
EP0416373A3 (en) 1992-05-27
AU6136090A (en) 1991-03-07

Similar Documents

Publication Publication Date Title
MC2040A1 (fr) Derives d'acides amines
MC2022A1 (fr) Derives d'acides amines
MC2151A1 (fr) Derives d'acides amines
MC2106A1 (fr) Derives d'aminoacides
MC2103A1 (fr) Derives d'aminoacides
MA26449A1 (fr) Derives d'acides amines .
DE59008394D1 (de) Aminosäureamid-Derivate.
NO920417D0 (no) Aminosyrederivater
DK340088A (da) Aminosyrederivater
DE69025723T2 (de) N-(Pyrrolo(2-3-d)pyrimidin-3-ylacyl)-Glutaminsäurederivate
FR2609998B1 (fr) Nouvelles substances antioxydantes derivees d'acides amines
MC1985A1 (fr) Derives d'acides amines
MC2107A1 (fr) Derives d'acides amines
DK0425925T3 (da) Substituerede aminosyreamid-derivater samt deres fremstilling og anvendelse
MC2264A1 (fr) Derives d'aminoacides
IT9021958A0 (it) Procedimento di purificazione dell'ammoniaca
MC1981A1 (fr) Derives d'acides catechol carboxyliques
PT75949A (fr) Procede pour la preparation de derives d'acides amines en n-(vinblastinoil-23)
MC2109A1 (fr) Dérivés d'acides aminés
DE69018816D1 (de) Aminosäurederivate.
FR2508036B1 (fr) Nouveaux derives d'acides amines na-3-cyano-propanoiques et application de ces derives
KR900007857A (ko) 1,4,2-옥사자포스폴리딘-4-아세트산, 2-알콕시-2-옥사이드의 아민염
DE59002430D1 (de) Cyclopropanoylaminosäureamid-Derivate.
NO924423D0 (no) Aminosyrederivater
FR2596762B1 (fr) Derives d'acides nucleiques

Legal Events

Date Code Title Description
YP Annual fee paid